ArticleCirculation research2021
Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.
Open access · greenAbstract read
In one paragraph
Article in Circulation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 65 citations in OpenAlex.
- Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes.International journal of molecular sciences · 2024Trial
- Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention.EBioMedicine · 2023Trial
- Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial.Clinical and translational medicine · 2022Trial
- Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022Trial
- Annexin A1 and Dexamethasone Treatment in Hospitalized COVID-19 Patients: Impact on Disease Recovery and Evidence for an Interplay Between Proresolving Mediators.Biomolecules · 2026Article
- Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication.Molecular biomedicine · 2026Review
- Integrated miR-omics and proteomics reveal the regulatory role of miR in protein networks associated with COVID-19 disease progression.Frontiers in immunology · 2026Article
- COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia.Microorganisms · 2025Article
- Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era.Cancer medicine · 2025Article
- Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS-CoV-2 Infection.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025Article
- The potential of exogenous specialized pro-resolving mediators in protecting against sepsis-associated lung injury: a review.Frontiers in pharmacology · 2025Review
- Article
- Biology and Total Synthesis of n-3 Docosapentaenoic Acid-Derived Specialized Pro-Resolving Mediators.Molecules (Basel, Switzerland) · 2024Review
- Identification of novel FRedox biology · 2024Article
- Efferocyte-Derived MCTRs Metabolically Prime Macrophages for Continual Efferocytosis via Rac1-Mediated Activation of Glycolysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators.Experimental biology and medicine (Maywood, N.J.) · 2023Review
- Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.Molecules (Basel, Switzerland) · 2023Review
- Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis.Immunobiology · 2023Article
- Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 2 institutions in 1 country.
Duco Steven KoenisWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Issa Beegun *William Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Charlotte Camille Jouvene *William Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Gabriel Amador AguirreBarts Cancer Institute (G.A.A., H.M.K.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Patricia Regina SouzaWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Maria Gonzalez-NunezWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Lucy LyWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Kimberly PistoriusWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Hemant M KocherBarts Cancer Institute (G.A.A., H.M.K.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
William RickettsDepartment of Respiratory Medicine, Barts Health NHS Trust, London, United Kingdom (W.R., G.T., P.P.).
Gavin ThomasDepartment of Respiratory Medicine, Barts Health NHS Trust, London, United Kingdom (W.R., G.T., P.P.).
Mauro PerrettiWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Ghassan AlusiWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Paul PfefferWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Jesmond DalliWilliam Harvey Research Institute (D.S.K., I.B., C.C.J., P.R.S., M.G.N., L.L., K.P., M.P., G.A., P.P., J.D.), Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Queen Mary University of London · GBBarts Health NHS Trust · GB
Funding
European Research Council 677542Wellcome Trust 107613
Abstract
[Figure: see text].
Indexed as
Cells, CulturedCOVID-19HumansInflammation MediatorsLeukocytes, MononuclearNeutrophilsPhagocytesInflammation Mediatorscovid-19homeostasisinflammation mediatorsmacrophagesmonocyteneutrophilsomega-3 fatty acidsphenotypeplasma
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.